Adjuvant-free immunization with infective filarial larvae as lymphatic homing antigen carriers.
Catherine CardDavid S WilsonSachiko HirosueMarcela Rincon-RestrepoAlexandre de TittaEsra GüçCoralie MartinOdile BainMelody A SwartzWitold W KilarskiPublished in: Scientific reports (2020)
Controlled infection with intestinal nematodes has therapeutic potential for preventing the symptoms of allergic and autoimmune diseases. Here, we engineered larvae of the filarial nematode Litomosoides sigmodontis as a vaccine strategy to induce adaptive immunity against a foreign, crosslinked protein, chicken egg ovalbumin (OVA), in the absence of an external adjuvant. The acylation of filarial proteins with fluorescent probes or biotin was not immediately detrimental to larval movement and survival, which died 3 to 5 days later. At least some of the labeled and skin-inoculated filariae migrated through lymphatic vessels to draining lymph nodes. The immunization potential of OVA-biotin-filariae was compared to that of an OVA-bound nanoparticulate carrier co-delivered with a CpG adjuvant in a typical vaccination scheme. Production of IFNγ and TNFα by restimulated CD4+ cells but not CD8+ confirmed the specific ability of filariae to stimulate CD4+ T cells. This alternative method of immunization exploits the intrinsic adjuvancy of the attenuated nematode carrier and has the potential to shift the vaccination immune response towards cellular immunity.
Keyphrases
- lymph node
- immune response
- early stage
- aedes aegypti
- drosophila melanogaster
- induced apoptosis
- rheumatoid arthritis
- dendritic cells
- living cells
- sentinel lymph node
- small molecule
- dna methylation
- cell cycle arrest
- quantum dots
- nk cells
- human health
- oxidative stress
- gene expression
- computed tomography
- pet imaging
- toll like receptor
- pet ct
- free survival
- rectal cancer